title: F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy.
authors.affiliation: Institut Pasteur, Antananarivo, Madagascar. chanteau@pasteur.pasteur.mg
authors.forename: S
authors.initials: S
authors.lastname: Chanteau
authors.forename: L
authors.initials: L
authors.lastname: Rabarijaona
authors.forename: T
authors.initials: T
authors.lastname: O'Brien
authors.forename: L
authors.initials: L
authors.lastname: Rahalison
authors.forename: J
authors.initials: J
authors.lastname: Hager
authors.forename: P
authors.initials: P
authors.lastname: Boisier
authors.forename: J
authors.initials: J
authors.lastname: Burans
authors.forename: M
authors.initials: M
authors.lastname: Rasolomaharo
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000942:Antigens, Bacterial / Q000097:blood*; D001426:Bacterial Proteins / Q000097:blood*; D015415:Biomarkers / Q000097:blood; D006801:Humans; D008270:Madagascar / Q000453:epidemiology; D010930:Plague / Q000175:diagnosis* / Q000188:drug therapy; D011379:Prognosis; D013307:Streptomycin / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use; D015010:Yersinia pestis / Q000276:immunology* / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D015415:Biomarkers; C086725:caf1 protein, Yersinia pestis; D014295:Trimethoprim; D013420:Sulfamethoxazole; D013307:Streptomycin